151 results on '"Isenberg D"'
Search Results
2. PO145 Strange rheuminations
3. Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double‐Blind, Placebo‐Controlled Trials
4. Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
5. Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes
6. Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome
7. Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome: 17
8. Lymphoma Risk in Systemic Lupus: Effects of Disease Activity Versus Treatment.: 2570
9. Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus
10. SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus
11. An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA
12. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs
13. Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus
14. Cardiac magnetic resonance imaging in patients with systemic lupus erythematosus
15. Serendipitous evidence of T lymphocyte activation in close female relatives of patients with systemic lupus erythematosus
16. In vivo inhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of β2-glycoprotein I: proof of concept
17. A RETROSPECTIVE SEVEN-YEAR ANALYSIS OF THE USE OF B-CELL DEPLETION THERAPY IN SYSTEMATIC LUPUS ERYTHEMATOSUS AT UNIVERSITY COLLEGE LONDON HOSPITAL: THE FIRST FIFTY PATIENTS: C01
18. Comment on: Prevalence, serological features, response to treatment and outcome of critical peripheral ischaemia in a cohort of lupus patients
19. EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints
20. EULAR points to consider for conducting clinical trials in systemic lupus erythematosus
21. Why do patients with systemic lupus erythematosus take or fail to take their prescribed medications? A qualitative study in a UK cohort
22. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus
23. Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus
24. Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease
25. The British Society for Rheumatology Biologics Register: 6 years on
26. Prolonged B-cell depletion following rituximab therapy in systemic lupus erythematosus: a report of two cases
27. Prevalence, serological features, response to treatment and outcome of critical peripheral ischaemia in a cohort of lupus patients
28. The Sjögrenʼs Syndrome Damage Index—a damage index for use in clinical trials and observational studies in primary Sjögrenʼs syndrome
29. Autoimmunity manifesting as dermatomyositis associated with oligoastrocytoma and dendritic cell immunotherapy
30. B cell depletion therapy in systemic lupus erythaematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response
31. BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000
32. Association of Kikuchi–Fujimotoʼs disease with SLE
33. SLE patients with renal damage incur higher health care costs
34. Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: Results from an international inception cohort study
35. B cell depletion therapy for patients with systemic lupus erythaematosus results in a significant drop in anticardiolipin antibody titres
36. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics
37. Aggressive CNS lupus vasculitis in the absence of systemic disease activity
38. The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case–cohort study
39. Sjögrenʼs Systemic Clinical Activity Index (SCAI)—a systemic disease activity measure for use in clinical trials in primary Sjögrenʼs syndrome
40. Muscular dystrophy mimicking refractory idiopathic inflammatory myositis: a trio of cases
41. Development of additional autoimmune diseases in a multiethnic cohort of patients with systemic lupus erythematosus with reference to damage and mortality
42. 30 million, around 10 000 … and 18 … Figuring out the optimal treatment for musculoskeletal conditions in the National Health Service
43. A comparison of autoimmune liver disease in juvenile and adult populations with systemic lupus erythematosus—a retrospective review of cases
44. Fifty years of anti-ds DNA antibodies: are we approaching journey's end?
45. Treatment adherence and clinical outcome in systemic lupus erythematosus
46. Antibodies toward High-Density Lipoprotein Components Inhibit Paraoxonase Activity in Patients with Systemic Lupus Erythematosus
47. Hodgkin's lymphoma in systemic lupus erythematosus
48. Lupus — origins and outcome: 37
49. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: An international inception cohort study
50. Association of Antinucleosome Antibodies With Disease Flare in Serologically Active Clinically Quiescent Patients With Systemic Lupus Erythematosus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.